Noble Registry

Every man deserves access to adequate prostate cancer diagnostic imaging. Nobody Left Behind.

[Noble Registry @NobleRegistry]

A first patient has been imaged in Indonesia!

Dr Yudistiro said “It's an honour to be involved with NOBLE. In Indonesia there are only 5 PET/CT centers. This SPECT-based candidate has potential to bring PSMA imaging to many more men with prostate cancer”

https://t.co/vrO3LHHZbX

[Noble Registry @NobleRegistry]

A 1st patient has been imaged in NOBLE Registry Azerbaijan!

PI Dr Novruzov, said: “It is wonderful to watch how a previously unattainable diagnostic modality (advanced PSMA imaging) has potential to be made available for everyone, leaving nobody behind!”

https://t.co/uC3rrzwoeK

[Noble Registry @NobleRegistry]

#NobleRegistry is led by an international committee made up of globally recognized Investigators, presently in 8 countries aiming to deliver & publish real-world evidence & clinical practice guidelines on the use of #SPECT imaging for #prostatecancer. https://t.co/uC3rrzeMQa

[Noble Registry @NobleRegistry]

To address global inequities in access to #diagnosticimaging, #NobleRegistry is dedicated to develop an efficient option through more widely available #SPECT #imaging allowing #prostatecancer patients to access #PSMA scan when indicated, to make sure that NOBody is LEft behind.

[Noble Registry @NobleRegistry]

To address global inequities in access to #diagnosticimaging, #NobleRegistry is dedicated to develop an efficient option through more widely available #SPECT #imaging allowing #prostatecancer patients to access #PSMA scan when indicated, to make sure that NOBody is LEft behind.

[Noble Registry @NobleRegistry]

A 1st patient has been imaged in Mexico! #ProstateCancer is the most common cancer & leading cause of cancer death in men over 50 years old in Mexico. Our aim is to help enable broad access to advanced #diagnosticimaging for every man living with PCa 👉 https://t.co/tyXe614W0G

[Noble Registry @NobleRegistry]

On #WorldCancerDay, the #NOBLERegistry joins the endeavor to "close the care gap" by making sure that, regardless of origin or financial situation, NOBody is LEft behind when it comes to #cancercare.
@uicc
Learn more: https://t.co/wEmkEnVLoS
Act now: https://t.co/4AYr8jfIrb

[Noble Registry @NobleRegistry]

Discover the article by Dr. Omar Yehia, PI at the MISR Radiology Center in Egypt for the #NOBLERegistry regarding the encouraging early results in the investigational use of 99mTc-iPSMA for #prostatecancer screening
#SPECT #seeittreatit #cancercare
https://t.co/KaJnhhy7vH

[Noble Registry @NobleRegistry]

Movember is almost over but it's always the right time to remember that every man deserves access to adequate #prostatecancer #diagnosticimaging. Learn more about the NOBLE Project 👉 https://t.co/vrO3LHHZbX
#Movember #cancercare #iPSMA #SPECTimaging #seeittreatit

[Noble Registry @NobleRegistry]

NOBLE Registry brings advanced #prostatecancer imaging to rural Australia with the first patient dosed. Read more 👉 https://t.co/S0aYSD55Fn
#cancercare #precisiononcology #nuclearmedicine #iPSMA #SPECTimaging #NObodyLEftbehind

[Noble Registry @NobleRegistry]

The new website is out! From the name to the aim, from the numbers that outnumber, from the international collaboration to a potential access transformation, get deep insight about the project aiming to ensure that NOBody is LEft behind.

https://t.co/vrO3LHHZbX

#prostatecancer

[Noble Registry @NobleRegistry]

Learn more about the #NobleRegistry at ICPO Forum for Theranostics in Precision Oncology October 19, 10:45-11:10 am (CEST). Learn about the project & the potential of 99mTc-PSMA-SPECT imaging in the diagnosis and staging of men living with #prostatecancer

https://t.co/9Z6XlEnk3z

[Noble Registry @NobleRegistry]

We aim to enable men living with #prostatecancer, whoever & wherever they are, to access PSMA SPECT imaging. We are thrilled to be part of the project as it aims to bring together different actors of the field around the same table to accomplish a common goal: Nobody Left Behind.

[Noble Registry @NobleRegistry]

"We are grateful to the patients that are making this registry study possible and helping to deliver an important milestone toward improving access to this important technology." - Dr. Christian Behrenbruch, CEO @TelixPharma.

#NOBLERegistry #OncidiumFoundation #ProstateCancer

[Noble Registry @NobleRegistry]

#NobleRegistry is supported by the @OncidiumFoundat, a non-profit organization focused on the development of #radiotheranostics for better patient access & @TelixPharma a radiopharmaceutical company developing diagnostic and therapeutic products (#theranostics). #NobodyLeftBehind

[Noble Registry @NobleRegistry]

#NobleRegistry is supported by the @OncidiumFoundat, a non-profit organization focused on the development of #radiotheranostics for better patient access & @TelixPharma a radiopharmaceutical company developing diagnostic and therapeutic products (#theranostics). #NobodyLeftBehind

[Noble Registry @NobleRegistry]

Every man deserves access to adequate #prostatecancer #diagnosticimaging. #NobleRegistry aims to enable all men with prostate cancer, regardless of origin or financial situation, to access PSMA-SPECT imaging to improve #earlydetection & better #cancercare.
#iPSMA #seeittreatit

[Noble Registry @NobleRegistry]

Did you know? #Prostatecancer remains the most frequently diagnosed cancer type in men & the fourth most common cancer worldwide (Globocan 2020). Thus, #earlydetection is a public health priority to improve & save lives, globally.
#diagnosis #NobleRegistry #iPSMA #seeittreatit

[Noble Registry @NobleRegistry]

Promising results following the initial experience using Tc-PSMA led by Dr. Yehia Omar within the #NobleRegistry, potentially opening up new options for diagnosis for men with #prostatecancer in countries that have little or no access to PET/CT or PSMA-PET tracers.
#iPSMA

[Noble Registry @NobleRegistry]

Promising results following the initial experience using Tc-PSMA led by Dr. Yehia Omar within the #NobleRegistry, potentially opening up new options for diagnosis for men with #prostatecancer in countries that have little or no access to PET/CT or PSMA-PET tracers.
#iPSMA